Opti Capital Management »

Biomarin Pharma Inc convertible/ shares owned by Opti Capital Management

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.5M 7.6M 0.98
2021-12-31 $8.6M 8.1M 1.06
2021-09-30 $18M 18M 1.03
2021-06-30 $28M 27M 1.04

More positions owned by Opti Capital Management

Insight Enterprises Note 0.750% 2/1
Royal Caribbean Group Note 6.000% 8/1
Unity Software Note 11/1
Novocure Note 11/0
Bentley Sys Note 0.125% 1/1
Blackline Note 3/1
Five9 Note 0.500% 6/0
Glaukos Corp Note 2.750% 6/1
Alarm Com Hldgs Note 1/1
Nuvasive Note 0.375% 3/1
Fastly Note 3/1
Omnicell Note 0.250% 9/1
Alnylam Pharmaceuticals Note 1.000% 9/1
Innoviva Note 2.500% 8/1
Alphatec Hldgs Note 0.750% 8/0

View all positions for Opti Capital Management

Top funds holding Biomarin Pharma Inc convertible/

Lord, Abbett & Co
Bank of America Corporation
Millennium Management
Citigroup
Aviva
Sona Asset Management
Tenor Capital Management
Shaolin Capital Management
Sunrise Partners Limited Partnership
Partner Fund Management
Moore Capital Management
Thrivent Financial for Lutherans
MacKay Shields
Jpmorgan Chase & Co
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/